LogicBio Therapeutics, Inc. (OTC:LOGC)
Industry: Technology

LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect. Its lead product candidate is LB-001 for the treatment of Methylmalonic Acidemia, a life-threatening disease that presents at birth. The company has a partnership with Children's Medical Research Institute to develop new viral vectors. LogicBio Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.

Current Quote*
Last: $7.660
Change: 0.150
Book: $3.278
Volume: 47,625

As Of: 12/06 17:36 ET
*Quotes delayed by 20min.

Graphs for LOGC


3 Month Graph


6 Month Graph


1 Year Graph